These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 3874920

  • 1. Thalidomide--effect on T cell subsets as a possible mechanism of action.
    Moncada B, Baranda ML, González-Amaro R, Urbina R, Loredo CE.
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):201-5. PubMed ID: 3874920
    [Abstract] [Full Text] [Related]

  • 2. [Should thalidomide be rehabilitated?].
    Belaube P, Garcin G, Marchand JP, Privat Y.
    Sem Hop; 1983 Dec 08; 59(45):3101-4. PubMed ID: 6320398
    [Abstract] [Full Text] [Related]

  • 3. A review of thalidomide's history and current dermatological applications.
    Perri AJ, Hsu S.
    Dermatol Online J; 2003 Aug 08; 9(3):5. PubMed ID: 12952752
    [Abstract] [Full Text] [Related]

  • 4. Thalidomide in lepra reaction (ENL) in lepromatous leprosy patients.
    Chandorkar AG, Burte NP, Jadhav JH, Gade RK, Bulakh PM, Tayshete SN, Kale VM.
    Indian J Lepr; 1984 Aug 08; 56(2):264-8. PubMed ID: 6548496
    [Abstract] [Full Text] [Related]

  • 5. Thalidomide: an experience in therapeutic outcome and adverse reactions.
    Sharma NL, Sharma VC, Mahajan VK, Shanker V, Ranjan N, Gupta M.
    J Dermatolog Treat; 2007 Aug 08; 18(6):335-40. PubMed ID: 17852637
    [Abstract] [Full Text] [Related]

  • 6. Treatment of chronic erythema nodosum leprosum with cyclosporine A produces clinical and immunohistologic remission.
    Miller RA, Shen JY, Rea TH, Harnisch JP.
    Int J Lepr Other Mycobact Dis; 1987 Sep 08; 55(3):441-9. PubMed ID: 3309088
    [Abstract] [Full Text] [Related]

  • 7. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY, Achirafi A, Flageul B.
    Acta Leprol; 2003 Sep 08; 12(3):117-22. PubMed ID: 15040702
    [Abstract] [Full Text] [Related]

  • 8. The role of thalidomide in the management of erythema nodosum leprosum.
    Walker SL, Waters MF, Lockwood DN.
    Lepr Rev; 2007 Sep 08; 78(3):197-215. PubMed ID: 18035771
    [Abstract] [Full Text] [Related]

  • 9. Thalidomide: a re-look.
    Grover JK, Vats V, Gopalakrishna R, Ramam M.
    Natl Med J India; 2000 Sep 08; 13(3):132-41. PubMed ID: 11558112
    [Abstract] [Full Text] [Related]

  • 10. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M, Brandsma JW, Faber WR, Bhattarai B, Feuth T, Anderson AM.
    Lepr Rev; 2008 Sep 08; 79(3):254-69. PubMed ID: 19009975
    [Abstract] [Full Text] [Related]

  • 11. Studies on T cell subsets and functions in leprosy.
    Bach MA, Chatenoud L, Wallach D, Phan Dinh Tuy F, Cottenot F.
    Clin Exp Immunol; 1981 Jun 08; 44(3):491-500. PubMed ID: 6459897
    [Abstract] [Full Text] [Related]

  • 12. Tr, T mu and B lymphocytes in erythema nodosum leprosum reactions of leprosy.
    Rao TD, Rao PR.
    Indian J Lepr; 1986 Jun 08; 58(4):601-8. PubMed ID: 2952738
    [Abstract] [Full Text] [Related]

  • 13. Tissue and blood T-lymphocyte subpopulations in erythema nodosum leprosum.
    Modlin RL, Bakke AC, Vaccaro SA, Horwitz DA, Taylor CR, Rea TH.
    Arch Dermatol; 1985 Feb 08; 121(2):216-9. PubMed ID: 3156560
    [Abstract] [Full Text] [Related]

  • 14. Thalidomide: new preparation. For well-defined indications.
    Prescrire Int; 1998 Oct 08; 7(37):131-4. PubMed ID: 10848043
    [Abstract] [Full Text] [Related]

  • 15. Thalidomide levels in patients with erythema nodosum leprosum.
    Vieira JL, Valente Mdo S.
    Ther Drug Monit; 2009 Oct 08; 31(5):602-3. PubMed ID: 19704404
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In situ characterization of T lymphocyte subsets in the reactional states of leprosy.
    Modlin RL, Gebhard JF, Taylor CR, Rea TH.
    Clin Exp Immunol; 1983 Jul 08; 53(1):17-24. PubMed ID: 6223731
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Thalidomide in leprosy and some dermatological conditions--a review.
    Parikh DA, Maniar JK, Ganapati R.
    Indian J Lepr; 1985 Jul 08; 57(4):862-7. PubMed ID: 3915010
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.